Asthmatin 5

Rx

Indications:

• The prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older.
• The relief of symptoms of seasonal allergic rhinitis in adults and pediatric patients 2 years of age and older, and perennial allergic rhinitis in adults and pediatric patients 6 months of age and older.

Dosage: 

• Asthmatin 5 should be taken once daily.
• Asthma or allergic rhinitis:
  Adult and adolescents ≥ 15 years of age: 10 mg
  Pediatric patients 6 to 14 years of age: 5 mg
  Pediatric patients 2 to 5 years old of age: 4 mg
• Pediatric patients 12 to 23 months of age with asthma: 4 mg (packet of oral granules)
  
• Pediatric patients 6 to 23 months of age with perennial allergic rhinitis: 4 mg (packet of oral granules).
• Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis and in patients less than 12 months of age with asthma have not been established.

Usage:

• For asthma or both asthma and allergic rhinitis, should take in the evening.
• For allergic rhinitis, the time of administration may be individualized to suit patient needs.

Known hypersensitivity to any of the active substance or excipients.

• Very common:
  Upper respiratory infections, hypersensitivity reactions including anaphylaxis.
• Common:
  Diarrhoea, vomiting, nausea; elevated levels of serum transaminases (ALT, AST); rash; fever.

• Montelukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks.
• Should not be: abruptly substituted for inhaled or oral corticosteroids; used as monotherapy for the treatment and management of exercise-induced bronchospasm.
• Patients with known aspirin sensitivity: continue avoidance of aspirin/NSAIDs while taking montelukast.
• Patients with phenylketonuria (PKU).
• Montelukast should be used during pregnancy only if clearly essential. Caution should be exercised when montelukast is given to a nursing mother.
• Caution should be exercised when patients drive or operate machinery.